Myeloma, also known as multiple myeloma, is more malignant and faster deteriorating, but with aggressive treatment, it can be effective in prolonging a patient’s life. The development of multiple myeloma is associated with factors such as family genetics, long-term exposure to toxic chemicals, and exposure to radiation, which can lead to overproduction of plasma cells and faster tumor development. The natural course of untreated multiple myeloma averages 6 to 12 months, but survival is greatly extended with aggressive treatment. Patients can be treated with drugs such as bortezomib, cyclophosphamide, lenalidomide, etc., as prescribed by the doctor, and surgical treatment is also required for patients who have caused pathologic fractures. Some patients can get better treatment effect after active treatment, slow down the progress of the disease, and may even achieve clinical cure. It is recommended that patients go to the local hospital as soon as possible, and actively cooperate with the doctor’s treatment in order to prevent the disease from being delayed.